Chemed closed at $548.64 on Nov 4, up 2.81%, 0.7% below its 52-week closing high. Volume of 227.2K shares was 1.52× its 20-day average (above normal).
Split-adjusted performance: +7.6% over one month, +29.2% over six months, +24.5% over one year.
In the quarter ended Sep 30, 2026, revenue was $690.94M, up 10.6% from a year earlier, with a net margin of 10.4%.
Short interest was 686.0K shares at the Oct 15 settlement, up 15.0% from the prior report (5.4% of float, 4.9 days to cover).